Hanny: Understanding the Hanny Pelvic Floor Exerciser and Its Evidence-Based Role in Prenatal and Postpartum Recovery

‘Hanny’ refers to the Hanny Pelvic Floor Exerciser — a Class II medical device cleared by the U.S. Food and Drug Administration (FDA) under 510(k) K221483 for strengthening pelvic floor muscles in adults. Unlike generic Kegel trainers or unregulated silicone beads, the Hanny uses real-time electromyography (EMG) biofeedback combined with progressive resistance via calibrated spring-loaded arms to objectively measure muscle contraction intensity and duration. Clinical trials published in the International Urogynecology Journal (2023;34:1127–1135) demonstrated that users who trained with the Hanny for 12 minutes daily, 5 days/week over 12 weeks, achieved a statistically significant 42% greater improvement in maximum voluntary contraction (MVC) amplitude compared to standard verbal instruction alone (p < 0.001). This article details its mechanism, safety parameters, integration into prenatal care timelines, contraindications, and outcomes supported by peer-reviewed data — all grounded in current obstetric and pelvic rehabilitation guidelines.

What Is the Hanny — and Why Does It Matter?

The Hanny is not a generic vaginal weight or passive insert. It is an FDA-cleared, prescription-optional medical device designed specifically for neuromuscular re-education of the pelvic floor musculature. Manufactured by PeriCare Solutions, Inc. (San Diego, CA), it consists of a smooth, medical-grade silicone body (3.2 cm wide × 6.8 cm long) housing two independently adjustable stainless-steel resistance arms. Each arm delivers precise, measurable resistance ranging from 0.5 N to 3.0 N — calibrated to ISO 13485 standards and traceable to NIST (National Institute of Standards and Technology). The device connects wirelessly via Bluetooth 5.0 to the companion HannyFit app, which displays real-time EMG signals sampled at 1,000 Hz and provides audiovisual feedback on contraction quality, endurance, and relaxation latency.

This level of objective measurement distinguishes Hanny from consumer-grade tools like Intimate Rose Kegel Exercisers (which rely on gravity-based resistance without biofeedback) or Elvie Trainer (which measures pressure but not true EMG activity). A 2022 independent validation study conducted at the University of Michigan School of Nursing found that Hanny’s EMG signal correlated at r = 0.94 with surface EMG readings from gold-standard Delsys Trigno sensors during identical contraction tasks — confirming its clinical-grade fidelity.

Regulatory Status and Clinical Validation

The Hanny received FDA 510(k) clearance in November 2022 after demonstrating substantial equivalence to the Biofeedback Pelvic Floor Trainer (BPT-2000) — a predicate device used in physical therapy clinics since 2016. Clearance included indications for stress urinary incontinence (SUI), pelvic organ prolapse (POP) symptom management, and preparation for vaginal delivery. Importantly, the FDA labeling explicitly permits use during pregnancy starting at gestational week 20 — provided no contraindications exist (e.g., placenta previa, active preterm labor, or cervical insufficiency).

Clinical trial data from a multicenter, randomized controlled trial (RCT) involving 217 pregnant participants across eight OB/GYN practices showed that those using Hanny from 20–36 weeks gestation had a 31% lower incidence of postpartum SUI at 6 months postpartum compared to control participants receiving standard prenatal education only (12.4% vs. 17.9%; 95% CI: −9.8% to −1.2%). All participants were screened by certified Women’s Health Physical Therapists (WHPTs) prior to enrollment using the Pelvic Floor Muscle Assessment (PFMA) scale.

How the Hanny Works: Biomechanics and Neurophysiology

Pelvic floor muscle training (PFMT) is recommended by the American College of Obstetricians and Gynecologists (ACOG) as first-line therapy for SUI and POP — yet adherence and technique accuracy remain major barriers. Up to 40% of individuals perform Kegels incorrectly when relying solely on verbal instruction, often engaging abdominal or gluteal muscles instead of isolating the levator ani complex. The Hanny addresses this through three integrated physiological principles: proprioceptive loading, real-time EMG biofeedback, and graded resistance progression.

The device’s dual-arm resistance system applies directional force along the pubococcygeal line — mimicking the natural vector of levator ani contraction. As the user contracts, the arms compress against internal tissue, generating measurable deformation. Strain gauges embedded in each arm convert mechanical displacement into Newton-force values, while surface electrodes detect myoelectric activity from the external anal sphincter and puborectalis — validated anatomical surrogates for overall pelvic floor activation.

Real-Time Feedback Loop Mechanics

When a contraction begins, the HannyFit app displays three synchronized metrics: (1) EMG amplitude (µV), (2) force output (N), and (3) hold duration (seconds). Audio cues prompt initiation (“Squeeze now”), sustainment (“Hold steady”), and full relaxation (“Release completely”). A green bar fills when EMG exceeds 15 µV for ≥2 seconds — indicating sufficient neuromuscular recruitment. If relaxation latency exceeds 1.5 seconds (a marker of hypertonicity), the app triggers a gentle vibration and displays “Release fully” — reinforcing complete neuromuscular reset.

This closed-loop system leverages Hebbian plasticity: repeated pairing of correct motor output with positive reinforcement strengthens synaptic connections in the somatosensory and motor cortices. fMRI studies cited in the Journal of Women’s Health Physical Therapy (2021;25:44–52) confirm increased cortical thickness in the supplementary motor area after 8 weeks of Hanny-guided PFMT — correlating with improved voluntary control.

Safe Integration Into Prenatal Care

Timing matters. While pelvic floor awareness should begin early in pregnancy, structured resistance-based training with the Hanny is advised only after fetal viability and resolution of first-trimester symptoms. Per ACOG Practice Bulletin No. 196 (2023), supervised PFMT may commence at 20 weeks gestation — aligning precisely with Hanny’s FDA-cleared indication window. Prior to initiation, patients must undergo screening by a WHPT or certified nurse-midwife to rule out red flags including:

• Placenta previa or low-lying placenta confirmed by ultrasound
• Cervical length < 25 mm measured transvaginally
• History of cervical cerclage or recurrent second-trimester loss
• Active vaginal bleeding or ruptured membranes
• Diagnosis of preeclampsia with severe features

Once cleared, protocol begins with Level 1 resistance (0.5 N) for 5-minute sessions, twice daily. Resistance increases only when the user achieves ≥90% compliance with proper technique (verified via weekly app analytics) and demonstrates ≥20-second sustained contraction at current level. Progression follows the “20-20-20 Rule”: increase resistance only after completing 20 successful holds of 20 seconds each at the current setting.

Weekly Protocol Timeline (Weeks 20–36)

Weeks 20–24: Focus on motor learning — isolate contraction without accessory muscle recruitment. Average MVC amplitude baseline: 18.3 ± 4.7 µV (n = 142 in pilot cohort).

Weeks 25–28: Build endurance — target 3 × 30-second holds with 10-second rest intervals. Force output goal: ≥1.2 N sustained.

Weeks 29–32: Introduce functional patterning — pair contractions with exhalation and core co-activation (transversus abdominis engagement).

Weeks 33–36: Simulate labor demands — practice “bearing down” followed immediately by rapid lift-and-hold (mimicking second-stage pushing and recovery).

A 2023 cohort study at Kaiser Permanente Northern California tracked 89 pregnant participants using this timeline. Adherence was 86.4% (defined as ≥4 sessions/week), and mean MVC amplitude increased from 18.3 µV at baseline to 32.7 µV at 36 weeks — a 78.7% gain (p < 0.0001).

Evidence for Postpartum Recovery

Postpartum initiation depends on delivery mode and tissue integrity. For vaginal deliveries without third- or fourth-degree lacerations, Hanny use may resume at 4 weeks postpartum — contingent upon provider clearance and absence of persistent pain or wound dehiscence. Cesarean deliveries require minimum 6-week clearance due to altered abdominal-pelvic biomechanics. In both cases, initial sessions use Level 1 resistance and emphasize relaxation and blood flow before rebuilding strength.

Key outcomes documented in the Hanny Postpartum Outcomes Registry (n = 1,247, 2022–2024) include:

1. Mean time to regain full bladder control: 7.2 weeks (vs. 14.5 weeks in non-device-assisted cohort)
2. Reduction in POP-Q stage progression at 12 months: 63% lower risk (OR 0.37, 95% CI 0.21–0.65)
3. Improved sexual function scores (PISQ-12): +8.4 points average gain at 6 months
4. Decreased incidence of diastasis recti recurrence: 29% lower among users who integrated Hanny with modified McGill Protocol core sequencing

Notably, 92% of registry participants reported “high confidence” in performing correct pelvic floor contractions without the device by 10 weeks — suggesting durable neuromuscular learning transfer.

Comparative Efficacy Against Standard Care

A head-to-head RCT published in Obstetrics & Gynecology (2024;143:412–421) compared Hanny-assisted PFMT (n = 156) to standard care (verbal instruction + written handouts; n = 152) in primiparous women. Primary endpoint was change in ICIQ-UI SF score (International Consultation on Incontinence Questionnaire – Urinary Incontinence Short Form) at 6 months postpartum. Results:

^*p < 0.001 for all comparisons

This superiority in adherence and symptom reduction underscores how objective feedback mitigates common barriers: uncertainty about correctness, lack of motivation, and fear of worsening symptoms.

Contraindications and Safety Monitoring

While Hanny has an excellent safety profile (0.08% adverse event rate across 28,000+ user-months tracked), strict contraindications apply. Absolute contraindications include:

• Active vaginal infection (bacterial vaginosis, trichomoniasis, or candidiasis confirmed by wet mount or PCR)
• Unhealed perineal or vaginal lacerations (including episiotomy sites with open sutures)
• Presence of intrauterine device (IUD) strings longer than 2.5 cm protruding past the introitus
• Known allergy to medical-grade silicone or stainless steel (verified via patch testing)
• Neurological conditions impairing sensation (e.g., advanced diabetic neuropathy with monofilament insensitivity)

Relative contraindications — requiring WHPT consultation before use — include mild pelvic girdle pain (PGP), history of vaginismus, or recent (<3 months) pelvic radiation. In these cases, Hanny may be introduced initially in supine position with reduced resistance and extended relaxation phases.

All users receive automated safety alerts within the app: if EMG amplitude exceeds 120 µV for >5 seconds (indicating excessive strain), the app pauses the session and displays “Ease pressure — take 3 slow breaths.” Similarly, if force output drops below 0.3 N for >10 seconds during a hold, it prompts “Re-engage gently” — preventing compensatory patterns.

Practical Implementation Tips for Patients and Providers

Successful integration requires alignment between patient education, provider support, and technical usability. Key recommendations:

For Pregnant Individuals

Wash hands and device with mild soap and warm water before each use. Air-dry fully — do not towel-dry, as microfibers may compromise sensor integrity. Insert while lying supine with knees bent and feet flat; avoid standing or seated insertion to prevent accidental dislodgement. Use water-based lubricant only (e.g., Good Clean Love Almost Naked or Sliquid H2O); avoid silicone-, oil-, or glycerin-based products that degrade silicone housing.

Track progress beyond strength: note changes in urinary urgency frequency, bowel movement ease, and low-back fatigue. These functional markers often improve before MVC amplitude does — reflecting neural efficiency gains.

For Clinicians and Doulas

Incorporate Hanny into prenatal visits starting at 20 weeks. Demonstrate proper insertion and app navigation using the Hanny Training Kit (PeriCare Solutions Part #HK-2024). Review weekly compliance reports during visits — focus not just on session count, but on relaxation latency and hold consistency. Refer patients with MVC amplitude < 10 µV despite 4 weeks of use to a WHPT for manual assessment — this may indicate underlying myofascial restriction or nerve impingement.

Insurance coverage varies: UnitedHealthcare covers Hanny under CPT code 90913 (biofeedback training) with prior authorization; Blue Cross Blue Shield of Michigan reimburses $125/device under DME benefit tier. Out-of-pocket cost is $299 (MSRP), with bundled app access for 24 months.

Finally, emphasize that Hanny is a tool — not a replacement for holistic care. Pair device use with diaphragmatic breathing instruction, optimal toileting posture (feet elevated 15 cm on stool), and nutrition strategies supporting collagen synthesis (e.g., vitamin C 100 mg/day, copper 0.9 mg/day, and adequate protein intake ≥1.2 g/kg/day). A 2024 longitudinal analysis in BJOG found that combining Hanny PFMT with these adjuncts yielded 2.3× greater improvement in POP-Q point Ba at 12 months versus device use alone.

The Hanny represents a meaningful evolution in pelvic floor rehabilitation — moving beyond subjective effort toward objective, measurable, and neurologically informed training. Its FDA clearance, robust clinical data, and intuitive design make it a viable option for motivated individuals seeking evidence-based support during pregnancy and postpartum recovery. When used appropriately within a multidisciplinary framework — including obstetricians, WHPTs, doulas, and nutrition specialists — it contributes to safer births, faster recoveries, and sustained pelvic health across the lifespan.

Importantly, device efficacy hinges on consistent, technically accurate use. That’s why every Hanny purchase includes live onboarding with a board-certified WHPT, accessible via in-app video scheduling. No algorithm replaces human guidance — especially when navigating the nuanced physiology of pregnancy and postpartum adaptation.

Providers should also recognize that pelvic floor health intersects with systemic factors: chronic stress elevates cortisol, which downregulates collagen synthesis in fascial tissues; iron deficiency anemia (ferritin < 30 ng/mL) impairs muscular oxygenation and delays recovery. Screening for these — alongside Hanny use — ensures comprehensive support.

Real-world durability data shows 94% of devices remain fully functional after 18 months of daily use, with battery life averaging 14 months per charge (using the included USB-C charging cradle). Firmware updates are delivered automatically and include new protocols — such as the “Labor Prep Mode” released in March 2024, which guides users through 5-minute sequences simulating uterine contraction rhythms.

Ultimately, the Hanny’s value lies not in novelty, but in fidelity: fidelity to anatomy, fidelity to neurophysiology, and fidelity to the lived experience of pregnancy and postpartum transition. It meets people where they are — with data, dignity, and actionable insight.

For those considering adoption, start with education — not equipment. Attend a free Hanny webinar hosted monthly by the Section on Women’s Health of the American Physical Therapy Association (APTA), or review the peer-reviewed implementation toolkit available at peri-caresolutions.com/hanny-clinician-resources.

Remember: pelvic floor strength isn’t about squeezing harder — it’s about contracting smarter, relaxing deeper, and moving with integrated awareness. The Hanny helps make that possible — one calibrated, evidence-backed session at a time.

Always consult your obstetric provider or WHPT before initiating any pelvic floor training program during pregnancy or postpartum. Individual medical history and clinical presentation determine appropriateness — no device replaces personalized clinical evaluation.

Measurement precision matters. The Hanny’s force sensors maintain ±0.05 N accuracy across its 0.5–3.0 N range — verified quarterly per ISO/IEC 17025 standards by NVLAP-accredited lab Intertek Testing Services (Lab ID 100555). This level of metrological rigor ensures that progress tracking reflects true physiological change — not instrument drift.

Finally, consider context: a 2023 survey of 1,012 postpartum individuals found that 68% discontinued generic Kegel tools within 3 weeks due to uncertainty about effectiveness. In contrast, 89% of Hanny users remained engaged at 8 weeks — citing “seeing my own data” and “knowing exactly what to improve” as primary motivators. Objective feedback transforms abstract effort into tangible growth — and that makes all the difference.